These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10589075)
1. The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma. Zengin N; Kars A; Sungur A; Zengin NI; Hayran M; Tekuzman G; Kansu E; Ruacan S; Firat D Am J Hematol; 1999 Dec; 62(4):208-11. PubMed ID: 10589075 [TBL] [Abstract][Full Text] [Related]
2. B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit. Pangalis GA; Roussou PA; Kittas C; Kokkinou S; Fessas P Cancer; 1987 Feb; 59(4):767-71. PubMed ID: 3492263 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bone-marrow pattern and immunophenotypic score in B-chronic lymphocytic leukemia at diagnosis. Jahic A; Iljazovic E; Arnautovic-Custovic A; Halilbasic A; Simendic V; Zabic A Med Arh; 2011; 65(3):132-6. PubMed ID: 21776871 [TBL] [Abstract][Full Text] [Related]
4. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications. Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A; Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815 [TBL] [Abstract][Full Text] [Related]
5. B-chronic lymphocytic leukemia. Disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern. Pangalis GA; Boussiotis VA; Kittas C Nouv Rev Fr Hematol (1978); 1988; 30(5-6):373-5. PubMed ID: 3222147 [TBL] [Abstract][Full Text] [Related]
6. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow biopsy in chronic lymphocytic leukemia. Rozman C; Montserrat E Nouv Rev Fr Hematol (1978); 1988; 30(5-6):369-71. PubMed ID: 3065734 [TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study. Molica S; Tucci L; Levato D; Docimo C Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and clinical staging in chronic lymphocytic leukemia. Rai KR; Han T Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow biopsy in chronic lymphocytic leukemia: a review of its prognostic importance. Montserrat E; Rozman C Blood Cells; 1987; 12(2):315-26. PubMed ID: 3304470 [TBL] [Abstract][Full Text] [Related]
11. Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-Hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis. Pangalis GA; Roussou PA; Kittas C; Mitsoulis-Mentzikoff C; Matsouka-Alexandridis P; Anagnostopoulos N; Rombos I; Fessas P Cancer; 1984 Aug; 54(4):702-8. PubMed ID: 6744204 [TBL] [Abstract][Full Text] [Related]
12. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. International CLL-IPI working group Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642 [TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862 [TBL] [Abstract][Full Text] [Related]
14. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study. Dhodapkar M; Tefferi A; Su J; Phyliky RL Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623 [TBL] [Abstract][Full Text] [Related]
15. Is bone marrow biopsy a prognostic parameter in B-CLL? Raphael M; Chastang C; Binet JL Nouv Rev Fr Hematol (1978); 1988; 30(5-6):377-8. PubMed ID: 3222148 [TBL] [Abstract][Full Text] [Related]
16. Sequential changes in the bone marrow trephine biopsy in B-cell chronic lymphocytic leukaemia. Robertson TI; Byth K Aust N Z J Med; 1993 Oct; 23(5):470-6. PubMed ID: 8297276 [TBL] [Abstract][Full Text] [Related]
17. Identification of a favorable subgroup of patients with generalized immunocytomas by follicular dendritic cells. Eisterer W; Hilbe W; Fend F; Ludescher C; Falk M; Thaler J Leukemia; 1995 Feb; 9(2):254-9. PubMed ID: 7869760 [TBL] [Abstract][Full Text] [Related]
18. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957 [TBL] [Abstract][Full Text] [Related]
19. The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia. Geisler C; Ralfkiaer E; Hansen MM; Hou-Jensen K; Larsen SO Br J Haematol; 1986 Jan; 62(1):47-54. PubMed ID: 3942695 [TBL] [Abstract][Full Text] [Related]
20. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Molica S; De Rossi G; Luciani M; Levato D Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]